Table I.
Cinnamon | Dose used | Case | Results | Reference |
---|---|---|---|---|
Cinnamomum burmannii 60 g/1 l water, heated at 100°C for 30 min |
100 ml/day, oral single dose | 30 non-diabetic cases (20–53 years) | Slightly decreased postprandial blood glucose after 2 h | Bernardo et al., 2015 [68] |
Cinnamomum burmannii Extract Herbilogy® |
2, 4, and 8 mg/kg B.W, orally for 28 days | 30 male, Swiss Webster mice on a high-fat diet | Decreased total cholesterol | Pulungan and Pane, 2020 [69] |
Cinnamomum burmannii Fine powder |
2 g per day, 8 weeks | 36 women aged more than 18 years, rheumatoid arthritis pre- and postmenopausal | Significant decrease in serum TNF-α, CRP, diastolic blood pressure and swollen joint count, and blood pressure | Shishehbor et al., 2018 [70] |
Cinnamomum cassia Bark |
1.5 g for 60 days | 99 type 2 diabetic patients | Reduced HbA1c, glucose, triglyceride, TG/HDL-C ratio, BP, and increased HDL and eGFR | Sengsuk et al., 2016 [53] |
Cinnamomum cassia Spray-dried aqueous extract |
250 mg twice a day, 2 months | 137 Chinese, mean age 61 years, fasting serum glucose: > 6.1 mmol/l | Reduced fasting insulin, glucose, total cholesterol, and LDL, improved insulin sensitivity | Anderson et al., 2016 [41] |
Cinnamomum verum Bark powder |
3 g/day, 8 weeks | 99 women with dyslipidemia | Reduced total cholesterol, triglyceride, and HDL, BW, BMI | Pishdad et al., 2018 [71] |
Cinnamomum zeylanicum | 85, 250, and 500 mg aqueous for 3 months | 28 healthy subjects | Reduced systolic and diastolic blood pressure and cholesterol. Renal and liver function, fasting blood glucose, HDL-c, VDL-d, and triglycerides were in the normal range, no changes in the anthropometric parameters | Ranasinghe et al., 2017 [72] |
Cinnamomum zeylanicum Bark powder |
Three capsules of 500 mg/daily for 8 weeks | 84 polycystic ovary syndrome women | Increased total antioxidant capacity and Malondialdehyde decreased. Improved total cholesterol, HDL, and LDL | Borzoei et al., 2018 [73] |
Iranian cinnamon powder | 3 g/day8 weeks | 39 type 2 diabetes patients, body mass index 27.7 | No significant effect in reduction of NF-κB, SIRT1, hs-CRP, IL-6, and TNF-α | Davari et al., 2020 [74] |
Cinnamic acid | 30 mg/kg/day for 7 weeks | Rats fed high-fat diet | Anti-obesity and cardioprotective | Mnafgui et al. (2015) [65] |
Cinnamaldehyde | 50 mg/kg for 7 weeks | Cardiac hypertrophy-induced mice by aortic banding | Improve cardiac hypertrophy and fibrosis | Yang et al. (2015) [40] |
Cinnamaldehyde | 10–100 µM | Isolated rat aortae subjected to vascular damage by methylglyoxal | Vasculoprotective effects | Tarkhan et al. (2018) [55] |
Cinnamon powder | 1000 mg/kg, 16 months | Type 2 diabetes cases | Preventing cardiac ischemia | Crawford et al. (2018) [70] |
Cinnamon extract | 500 mg/kg, 2 months | Type 2 diabetes cases | Decreased TC, HDL, LDL | Anderson et al. (2016) [41] |